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background:  In patients with heart failure (HF), atrial fibrillation (AF) is a common arrhythmia and has a significant association with 
an increased risk for mortality. The cumulative effects of ten genotypes susceptible to AF identified by meta-analysis of genome-wide 
association studies (GWAS) were reported to confer AF risk. However, little is known about genetic pathogenesis related to HF. The 
purpose of our study was to clarify the cumulative effects of 10 GWAS-proven single nucleotide polymorphisms (SNPs) in AF patients with 
HF, and to examine the influences of genetic pathogenesis in two clinical forms of HF.
Methods:  Two hundred seventy-eight patients with HF (200 with HF with preserved Ejection Fraction (EF) (HFPEF), 78 with HF with 
reduced EF (HFREF)) were enrolled in this study. Of these patients, 184 were diagnosed with AF and 93 were diagnosed with sinus 
rhythm (SR). We genotyped 10 SNPs validated by meta-analysis of GWAS for AF. The 10 SNPs were KCNN3-PMVK (rs6666258), PRRX1 
(rs3903239), PITX2 (rs6817105), WNT8A (rs2040862), CAV1 (rs3807989), C9orf3 (rs10821415), SYNPO2L (rs10824026), SYNE2 
(rs1152591), HCN4 (rs7164883), and ZFHX3 (rs2106261). Cumulative effects were calculated as a genotype risk score by summing the 
number of risk alleles from the 10 SNPs for each patient.
results:  In all HF patients, the total genotype risk score was significantly higher in patients with AF than in those with SR (7.1±0.9 vs 
6.4±0.7, P= 0.001). However, this cumulative genetic relationship with AF was not identified in patients with HFREF. The frequency of 
the risk allele in HCN4 gene was significantly higher in HFREF patients with AF than those with SR (p=0.012). On the other hand, this 
frequency tended to be lower in patients with AF than in those with SR (P=0.062) in HFPEF.
Conclusion:  We found that the genotype risk score based on 10 GWAS-proven SNPs for AF was significantly associated with AF in 
patients with heart failure. Additionally, HCN4 gene might play an inverse role in pathogenesis of AF between the two clinical forms of HF.
